Legal Representation
Attorney
B. Brett Heavner
USPTO Deadlines
Next Deadline
227 days remaining
Statement of Use Due - Extension 5 Granted
Due Date
March 21, 2026
Application History
34 events| Date | Code | Type | Description | Documents |
|---|---|---|---|---|
| Apr 24, 2025 | EXRA | E | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | Loading... |
| Apr 23, 2025 | EX5G | S | SOU EXTENSION 5 GRANTED | Loading... |
| Apr 1, 2025 | EEXT | I | SOU TEAS EXTENSION RECEIVED | Loading... |
| Apr 1, 2025 | EXT5 | S | SOU EXTENSION 5 FILED | Loading... |
| Mar 18, 2025 | EXRA | E | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | Loading... |
| Mar 17, 2025 | EX4G | S | SOU EXTENSION 4 GRANTED | Loading... |
| Jan 9, 2025 | EEXT | I | SOU TEAS EXTENSION RECEIVED | Loading... |
| Jan 9, 2025 | EXT4 | S | SOU EXTENSION 4 FILED | Loading... |
| Nov 22, 2024 | NOAC | E | CORRECTED NOA E-MAILED | Loading... |
| Nov 22, 2024 | DPCC | D | DIVISIONAL PROCESSING COMPLETE | Loading... |
| Oct 24, 2024 | AITU | A | CASE ASSIGNED TO INTENT TO USE PARALEGAL | Loading... |
| Aug 20, 2024 | ERTD | I | TEAS REQUEST TO DIVIDE RECEIVED | Loading... |
| Aug 20, 2024 | EX3G | S | SOU EXTENSION 3 GRANTED | Loading... |
| Aug 20, 2024 | EXT3 | S | SOU EXTENSION 3 FILED | Loading... |
| Aug 20, 2024 | EXRA | E | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | Loading... |
| Aug 20, 2024 | EEXT | I | SOU TEAS EXTENSION RECEIVED | Loading... |
| Aug 20, 2024 | DRRR | I | DIVISIONAL REQUEST RECEIVED | Loading... |
| Mar 13, 2024 | EXRA | E | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | Loading... |
| Mar 12, 2024 | EX2G | S | SOU EXTENSION 2 GRANTED | Loading... |
| Mar 12, 2024 | EXT2 | S | SOU EXTENSION 2 FILED | Loading... |
| Mar 12, 2024 | EEXT | I | SOU TEAS EXTENSION RECEIVED | Loading... |
| Sep 9, 2023 | EXRA | E | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | Loading... |
| Sep 7, 2023 | EXT1 | S | SOU EXTENSION 1 FILED | Loading... |
| Sep 7, 2023 | EEXT | I | SOU TEAS EXTENSION RECEIVED | Loading... |
| Sep 7, 2023 | EX1G | S | SOU EXTENSION 1 GRANTED | Loading... |
| Mar 21, 2023 | NOAM | E | NOA E-MAILED - SOU REQUIRED FROM APPLICANT | Loading... |
| Jan 24, 2023 | NPUB | E | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | Loading... |
| Jan 24, 2023 | PUBO | A | PUBLISHED FOR OPPOSITION | Loading... |
| Jan 4, 2023 | NONP | E | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | Loading... |
| Dec 19, 2022 | CNSA | P | APPROVED FOR PUB - PRINCIPAL REGISTER | Loading... |
| Dec 17, 2022 | DOCK | D | ASSIGNED TO EXAMINER | Loading... |
| Mar 12, 2022 | MDSC | E | NOTICE OF DESIGN SEARCH CODE E-MAILED | Loading... |
| Mar 11, 2022 | NWOS | I | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | Loading... |
| Mar 10, 2022 | NWAP | I | NEW APPLICATION ENTERED | Loading... |
Detailed Classifications
Class 005
human pharmaceuticals for the treatment of pulmonary diseases, pulmonary conditions, bronchoconstrictive diseases, bronchoconstrictive conditions; infectious diseases, neurological diseases and conditions, neuromuscular diseases and conditions, musculoskeletal disorders, and diseases and conditions associated with skeletal muscle dysfunction, skeletal muscle wasting, skeletal muscle atrophy, skeletal muscle weakness, metabolic diseases and disorders, diabetes, hypertension, vascular diseases, and diseases and conditions associated with dysfunction of non-muscle myosin
Additional Information
Design Mark
The mark consists of stylized "C" with a circle between the opening.
Color Claim
Color is not claimed as a feature of the mark.
Classification
International Classes
005